Delegates at the conference  will hear about the latest developments in nanobiotechnology. Topics include nano-enabled drug delivery technologies, biophotonics, biomaterials, nanobioanalytics, in vitro diagnostics, integrated systems and nano-enabled innovations in surgical devices and systems. Keynote speakers will include global experts and selected researchers in nanobiotechnology.

Dr Paul Galvin, Head of Life Sciences Interface Group at Tyndall National Institute,  UCC expressed his delight at welcoming some 140 delegates from more than 25 countries to Cork.  “The major focus of the NanoBio-Europe Congress in 2011 is on medical applications of nanobiotechnology, in which nanotechnology enabled devices and systems provide the basis for better, more accessible healthcare with improved outcomes for patients. Tyndall has 80 people working on research in nanobio. We are particularly interested in bringing the different scientific disciplines together to generate new solutions for healthcare and environmental applications. Hosting such a conference in Cork is a validation of the work throughout Ireland in the bio and ICT fields”, said Dr Galvin.

Picture: Dr Paul Galvin, Head of Life Sciences Interface Group, Tyndall National Institute and John Travers, Interim Director General, Science Foundation Ireland (SFI) at the Nanobio Europe Conference, UCC.

<<Previous ItemNext Item>>

« Back to 2011 Press Releases